These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21493261)

  • 1. Decontamination of nasal atomizer tips: alcohol versus guards.
    Kieff D; Fink D
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):411-3. PubMed ID: 21493261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative risks of bacterial contamination between a venturi atomizer and a positive displacement atomizer.
    Wolfe TR; Hillman TA; Bossart PJ
    Am J Rhinol; 2002; 16(4):181-6; discussion 186. PubMed ID: 12222941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-use Venturi nasal atomizer contamination in a clinical rhinologic practice.
    Dubin MG; White DR; Melroy CT; Gergan MT; Rutala WA; Senior BA
    Am J Rhinol; 2004; 18(3):151-6. PubMed ID: 15283488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unexpected route for otolaryngology bacterial contamination with a Venturi atomizer.
    Tseng TM; Chen PY; Tseng H; Lin HC; Chang CY; Hung SH
    Rhinology; 2014 Jun; 52(2):156-161. PubMed ID: 24932628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of possible cross-contamination with the Venturi system atomizer.
    Scianna JM; Chow JM; Hotaling A
    Am J Rhinol; 2005; 19(5):503-7. PubMed ID: 16270606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment for the presence of bacterial contamination of Venturi principle atomizers in a clinical setting.
    Rizzi M; Batra PS; Hall G; Citardi MJ; Lanza DC
    Am J Rhinol; 2005; 19(1):21-3. PubMed ID: 15794070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment of the risk of cross-infection with a multi-use nasal atomizer.
    Spraggs PD; Hanekom WH; Mochloulis G; Joseph T; Kelsey MC
    J Hosp Infect; 1994 Dec; 28(4):315-21. PubMed ID: 7897193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of patient cross-contamination from Venturi-Principle atomizers.
    Wolfe TR
    ORL Head Neck Nurs; 2005; 23(2):25-7. PubMed ID: 15916354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster of tuberculosis cases in North Carolina: possible association with atomizer reuse.
    Southwick KL; Hoffmann K; Ferree K; Matthews J; Salfinger M
    Am J Infect Control; 2001 Feb; 29(1):1-6. PubMed ID: 11172311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of decontamination efficacy of cleaning solutions on stainless steel and glass surfaces contaminated by 10 antineoplastic agents.
    Queruau Lamerie T; Nussbaumer S; Décaudin B; Fleury-Souverain S; Goossens JF; Bonnabry P; Odou P
    Ann Occup Hyg; 2013 May; 57(4):456-69. PubMed ID: 23223271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venturi atomizers as potential sources of patient cross-infection.
    Bossart PJ; Wolfe T
    Am J Infect Control; 2003 Nov; 31(7):441-4. PubMed ID: 14639443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
    Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
    Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination.
    French GL; Otter JA; Shannon KP; Adams NM; Watling D; Parks MJ
    J Hosp Infect; 2004 May; 57(1):31-7. PubMed ID: 15142713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of delivery of topical medications to the paranasal sinuses via "vertex-to-floor" position and atomizer spray after FESS.
    Cannady SB; Batra PS; Citardi MJ; Lanza DC
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):735-40. PubMed ID: 16274802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device.
    Vlckova I; Navrátil P; Kana R; Pavlicek P; Chrbolka P; Djupesland PG
    Rhinology; 2009 Dec; 47(4):419-26. PubMed ID: 19936370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection risk associated with a closed luer access device.
    Adams D; Karpanen T; Worthington T; Lambert P; Elliott TS
    J Hosp Infect; 2006 Mar; 62(3):353-7. PubMed ID: 16406139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective clinical trial to evaluate the microbial barrier of a needleless connector.
    Casey AL; Burnell S; Whinn H; Worthington T; Faroqui MH; Elliott TS
    J Hosp Infect; 2007 Mar; 65(3):212-8. PubMed ID: 17241691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of nasal irrigation bottle contamination.
    Keen M; Foreman A; Wormald PJ
    Laryngoscope; 2010 Oct; 120(10):2110-4. PubMed ID: 20824637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does nasal decontamination reduce the incidence of infections after cardiac surgery?].
    Jabbour H; Madi-Jebara S; Jabbour K; Yazigi A; Haddad F; Hayek G; Yazbeck P; Antakly MC
    J Med Liban; 2010; 58(2):65-70. PubMed ID: 20549891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.